MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
Over the last 12 months, insiders at MaxCyte, Inc. have bought $489,066 and sold $1.26M worth of MaxCyte, Inc. stock.
On average, over the past 5 years, insiders at MaxCyte, Inc. have bought $16.03M and sold $20.12M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Masoud Maher (President and CEO) — $489,066.
The last purchase of 70,443 shares for transaction amount of $345,241 was made by Masoud Maher (President and CEO) on 2024‑06‑10.
2024-06-20 | Sale | Ross Thomas M. | EVP, GLOBAL SALES | 33,333 0.0279% | $4.09 | $136,465 | +0.72% | |
2024-06-10 | Masoud Maher | President and CEO | 70,443 0.0666% | $4.90 | $345,241 | -8.37% | ||
2024-06-07 | Masoud Maher | President and CEO | 29,557 0.0283% | $4.87 | $143,824 | -3.70% | ||
2024-03-26 | Sale | Johnston John Joseph | director | 5,000 0.0049% | $4.41 | $22,025 | -2.64% | |
2024-01-26 | Sale | Johnston John Joseph | director | 5,000 0.0049% | $5.12 | $25,585 | -10.98% | |
2023-12-26 | Sale | Johnston John Joseph | director | 5,000 0.0048% | $4.53 | $22,650 | +1.13% | |
2023-12-05 | Sale | Doerfler Douglas | President and CEO | 99,442 0.0946% | $5.17 | $514,115 | -12.33% | |
2023-12-04 | Sale | Doerfler Douglas | President and CEO | 25,008 0.0241% | $5.01 | $125,290 | -8.39% | |
2023-12-01 | Sale | Doerfler Douglas | President and CEO | 20,200 0.0191% | $5.00 | $101,000 | -7.32% | |
2023-11-27 | Sale | Johnston John Joseph | director | 5,000 0.0048% | $4.59 | $22,950 | -1.08% | |
2023-11-14 | Sale | Johnston John Joseph | director | 10,000 0.0096% | $3.71 | $37,100 | +23.32% | |
2023-08-30 | Sale | Johnston John Joseph | director | 2,841 0.0027% | $3.70 | $10,512 | +18.55% | |
2023-07-26 | Sale | Johnston John Joseph | director | 5,000 0.0049% | $4.75 | $23,750 | -9.43% | |
2023-07-12 | Sale | Doerfler Douglas | President and CEO | 16,757 0.0164% | $5.02 | $84,120 | -12.80% | |
2023-07-11 | Sale | Doerfler Douglas | President and CEO | 12,798 0.0124% | $5.04 | $64,502 | -13.27% | |
2023-07-10 | Sale | Doerfler Douglas | President and CEO | 445 0.0004% | $5.01 | $2,229 | -11.82% | |
2023-06-27 | Sale | Johnston John Joseph | director | 7,471 0.0072% | $4.39 | $32,798 | -0.23% | |
2023-06-26 | Sale | Johnston John Joseph | director | 7,529 0.0074% | $4.49 | $33,805 | -0.39% | |
2023-06-14 | Sale | Doerfler Douglas | President and CEO | 28,883 0.028% | $5.04 | $145,570 | -11.86% | |
2023-06-13 | Sale | Doerfler Douglas | President and CEO | 14,968 0.0146% | $5.03 | $75,289 | -10.80% |
Doerfler Douglas | President and CEO | 333197 0.3213% | $3.98 | 0 | 23 | |
Johnston John Joseph | director | 120583 0.1163% | $3.98 | 0 | 9 | |
Masoud Maher | EVP and General Counsel | 100000 0% | $3.98 | 2 | 3 | |
Ross Thomas M. | EVP, Global Sales & Marketing | 25000 0% | $3.98 | 0 | 23 | |
Casdin Eli | director | 10000000 9.6423% | $3.98 | 0 | 2 | |
Casdin Partners Master Fund, L.P. | 10 percent owner | 10000000 9.6423% | $3.98 | 1 | 2 | <0.0001% |
Holtz Ron | SVP and CAO | 125251 0.1208% | $3.98 | 0 | 3 | |
DOUGLAS RICHARD | director | 100000 0.0964% | $3.98 | 2 | 0 | <0.0001% |
Murphy Amanda Louise | Chief Financial Officer | 0 0% | $3.98 | 0 | 3 |
BlackRock | $30.29M | 6.92 | 7.23M | -1.52% | -$468,496.47 | <0.01 | |
Cadian Capital Management LP | $27.49M | 6.28 | 6.56M | +16.22% | +$3.84M | 0.98 | |
Millennium Management LLC | $25.86M | 5.9 | 6.17M | +23.12% | +$4.86M | 0.02 | |
The Vanguard Group | $22.4M | 5.12 | 5.35M | +1.23% | +$272,366.76 | <0.0001 | |
Vitruvian Partners | $21.13M | 4.82 | 5.04M | 0% | +$0 | 6.7 | |
Morgan Stanley | $14.75M | 3.37 | 3.52M | +1.09% | +$159,664.16 | <0.01 | |
Fidelity Investments | $14.45M | 3.3 | 3.45M | +21.7% | +$2.58M | <0.01 | |
Massachusetts Financial Services Co Ma | $10.58M | 2.42 | 2.53M | -0.47% | -$50,238.10 | <0.01 | |
Mudita Advisors Llp | $9.53M | 2.18 | 2.28M | +20.94% | +$1.65M | 5.68 | |
Geode Capital Management | $8.92M | 2.04 | 2.13M | +1.52% | +$133,333.37 | <0.01 | |
State Street | $8.32M | 1.9 | 1.99M | +2.14% | +$173,998.14 | <0.0001 | |
River & Mercantile Asset Management LLP | $7.97M | 1.81 | 1.89M | +24.36% | +$1.56M | 2 | |
Portolan Capital Management | $7.21M | 1.65 | 1.72M | -37.55% | -$4.34M | 0.55 | |
Chevy Chase Trust Holdings Inc | $5.43M | 1.24 | 1.3M | +2,182.59% | +$5.19M | 0.02 | |
Arrowmark Colorado Holdings Llc | $5.27M | 1.2 | 1.26M | -8.41% | -$484,267.63 | 0.01 | |
Ameriprise Financial | $4.79M | 1.09 | 1.14M | -21.08% | -$1.28M | <0.01 | |
Dimensional Fund Advisors | $3.73M | 0.85 | 889,202 | +27.95% | +$813,869.93 | <0.01 | |
Northern Trust | $3.3M | 0.75 | 786,739 | -1.05% | -$34,973.94 | <0.01 | |
Silvercrest Asset Management Group Inc | $2.93M | 0.67 | 699,089 | +4.52% | +$126,575.71 | 0.02 | |
Blue Water Life Science Advisors Llc | $2.53M | 0.58 | 603,937 | -67.96% | -$5.37M | 2.38 | |
Willis Investment Counsel | $2.2M | 0.5 | 525,000 | -4.54% | -$104,750.00 | 0.15 | |
Roubaix Capital, LLC | $2.08M | 0.48 | 497,353 | +28.78% | +$465,726.86 | 1.32 | |
LAZARD ASSET MANAGEMENT LLC | $1.96M | 0.45 | 467,687 | +27.39% | +$420,979.61 | <0.01 | |
Alger | $1.67M | 0.38 | 399,162 | -1.95% | -$33,243.46 | 0.01 | |
BNY Mellon | $1.43M | 0.33 | 340,184 | -10.91% | -$174,509.32 | <0.0001 | |
Apollo Management Holdings L P | $1.29M | 0.3 | 307,987 | 0% | +$0 | 0.02 | |
Allspring Global Investments | $1.19M | 0.27 | 285,146 | -1.86% | -$22,651.15 | <0.01 | |
Rathbone Brothers | $1.22M | 0.27 | 282,876 | -6.02% | -$78,424.96 | 0.01 | |
Blair William Co Il | $1.14M | 0.26 | 273,064 | +7.27% | +$77,519.18 | <0.01 | |
Grandeur Peak Global Advisors, LLC | $1.05M | 0.24 | 250,743 | -61.83% | -$1.7M | 0.08 | |
Bleichroeder Lp | $1.08M | 0.24 | 250,000 | 0% | +$0 | 0.29 | |
Nuveen | $1.04M | 0.24 | 247,992 | 0% | +$0 | <0.0001 | |
Charles Schwab | $1.02M | 0.23 | 242,892 | -0.35% | -$3,565.69 | <0.0001 | |
JPMorgan Chase | $1.01M | 0.23 | 241,572 | +0.37% | +$3,741.67 | <0.0001 | |
Algert Global LLC | $876,000.00 | 0.2 | 209,015 | New | +$876,000.00 | 0.03 | |
Goldman Sachs | $774,559.00 | 0.18 | 184,859 | -6.37% | -$52,664.10 | <0.0001 | |
Swiss National Bank | $726,965.00 | 0.17 | 173,500 | 0% | +$0 | <0.0001 | |
Squarepoint Ops LLC | $708,705.00 | 0.16 | 169,142 | +51.87% | +$242,043.74 | <0.01 | |
Renaissance Technologies | $681,000.00 | 0.16 | 162,600 | -14.01% | -$110,987.09 | <0.01 | |
Ubs Asset Management Americas Inc | $619,943.00 | 0.14 | 147,958 | 0% | +$0 | <0.0001 | |
RhumbLine Advisers | $572,981.00 | 0.13 | 136,752 | +2.94% | +$16,344.91 | <0.01 | |
Bank of America | $556,230.00 | 0.13 | 132,752 | -8.6% | -$52,362.35 | <0.0001 | |
American Century Investments | $545,563.00 | 0.13 | 130,206 | +54.76% | +$193,033.25 | <0.0001 | |
VALMARK ADVISERS, INC. | $486,375.00 | 0.11 | 116,080 | +38.31% | +$134,721.02 | 0.01 | |
Alberta Investment Management Corporation | $458,994.00 | 0.11 | 109,545 | -19.53% | -$111,412.21 | <0.01 | |
Ohio Strs | $452,000.00 | 0.1 | 108,000 | -6% | -$28,877.78 | <0.01 | |
UBS | $404,050.00 | 0.09 | 96,432 | +0.9% | +$3,595.02 | <0.0001 | |
U.S. Bancorp | $401,620.00 | 0.09 | 95,852 | +959.96% | +$363,729.82 | <0.01 | |
M&T Bank | $369,044.00 | 0.08 | 88,054 | +0.21% | +$762.78 | <0.01 | |
CalSTRS | $369,638.00 | 0.08 | 88,219 | -4.83% | -$18,746.08 | <0.0001 |